Fitness Costs of Tigecycline Resistance in Acinetobacter baumannii and the Resistance Mechanism Revealed by a Transposon Mutation Library
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fitness Costs of Tigecycline Resistance in Acinetobacter baumannii and the Resistance Mechanism Revealed by a Transposon Mutation Library
Authors
Keywords
-
Journal
Antibiotics-Basel
Volume 11, Issue 10, Pages 1379
Publisher
MDPI AG
Online
2022-10-10
DOI
10.3390/antibiotics11101379
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients
- (2022) Jiangang Zhang et al. Microbiology Spectrum
- Bacterial hydrophilins promote pathogen desiccation tolerance
- (2022) Erin R. Green et al. Cell Host & Microbe
- Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review
- (2021) Sajad Yaghoubi et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Risk factors for nephrotoxicity associated with polymyxin B therapy in Chinese patients
- (2021) Jiali Zhang et al. International Journal of Clinical Pharmacy
- Idiosyncratic variation in the fitness costs of tetracycline‐resistance mutations in Escherichia coli
- (2021) Kyle J. Card et al. EVOLUTION
- Characteristics and diversity of mutations in regulatory genes of resistance-nodulation-cell division efflux pumps in association with drug-resistant clinical isolates of Acinetobacter baumannii
- (2021) Bahare Salehi et al. Antimicrobial Resistance and Infection Control
- A Four-year Follow-Up Survey of Antimicrobial Resistance Among Acinetobacter baumannii complex From Inpatients in Southern Brazil
- (2021) Leandro Reus Rodrigues Perez et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Phenotypic and genotypic characteristics of Acinetobacter baumannii enrolled in the relationship among antibiotic resistance, biofilm formation and motility
- (2021) Mona Mohamed Al-Shamiri et al. MICROBIAL PATHOGENESIS
- A Complementary Mechanism of Bacterial mRNA Translation Inhibition by Tetracyclines
- (2021) Victor Barrenechea et al. Frontiers in Microbiology
- Epidemiological Analysis of Multidrug-Resistant Acinetobacter baumannii Isolates in a Tertiary Hospital Over a 12-Year Period in China
- (2021) Meijie Jiang et al. Frontiers in Public Health
- Tigecycline efflux in Acinetobacter baumannii is mediated by TetA in synergy with RND-type efflux transporters
- (2020) Wuen Ee Foong et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Characterization of biofilm production in different strains of Acinetobacter baumannii and the effects of chemical compounds on biofilm formation
- (2020) Ming-Feng Lin et al. PeerJ
- A systematic review of implications, mechanisms, and stability of in vivo emergent resistance to colistin and tigecycline in Acinetobacter baumannii
- (2020) Stamatis Karakonstantis JOURNAL OF CHEMOTHERAPY
- Acinetobacter baumannii Resistance: A Real Challenge for Clinicians
- (2020) Rosalino Vázquez-López et al. Antibiotics-Basel
- Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a systematic review and network meta-analysis
- (2020) Jiating Liu et al. Journal of Global Antimicrobial Resistance
- Effects of sub-inhibitory concentrations of meropenem and tigecycline on the expression of genes regulating pili, efflux pumps and virulence factors involved in biofilm formation by Acinetobacter baumannii
- (2019) Tahereh Navidifar et al. Infection and Drug Resistance
- Urinary tract colonization is enhanced by a plasmid that regulates uropathogenic Acinetobacter baumannii chromosomal genes
- (2019) Gisela Di Venanzio et al. Nature Communications
- A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features
- (2019) Baris Boral et al. Annals of Clinical Microbiology and Antimicrobials
- Plasmid-encoded tet(X) genes that confer high-level tigecycline resistance in Escherichia coli
- (2019) Jian Sun et al. Nature Microbiology
- Multiple drug resistant Acinetobacter baumannii chloramphenicol resistance requires an inner membrane permease
- (2018) Andrew P-A. Karalewitz et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Diversity of mutations in regulatory genes of resistance-nodulation-cell division efflux pumps in association with tigecycline resistance in Acinetobacter baumannii
- (2018) Stefanie Gerson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Molecular mechanisms of antibiotic resistance in Acinetobacter baumannii with a special focus on its epidemiology in Lebanon
- (2018) Sabah Jamal et al. Journal of Global Antimicrobial Resistance
- DETECTION OF AMINOGLYCOSIDE AND QUINOLONE RESISTANCE GENES AND EVALUATION OF POLYMYXIN B SUSCEPTIBILITY PROFILE IN ACINETOBACTER BAUMANNII CLINICAL ISOLATES IN TEHRAN, IRAN DURING 2015-2016
- (2018) Mohsen Heidary Mediterranean Journal of Hematology and Infectious Diseases
- Acinetobacter baumannii maintains its virulence after long-time starvation
- (2018) Itziar Chapartegui-González et al. PLoS One
- The distribution of antibiotic use and its association with antibiotic resistance
- (2018) Scott W Olesen et al. eLife
- In Vitro Activity of Various Antibiotics in Combination with Tigecycline Against Acinetobacter baumannii: A Systematic Review and Meta-Analysis
- (2017) Jian Li et al. Microbial Drug Resistance
- Metabolic constraints on the evolution of antibiotic resistance
- (2017) Mattia Zampieri et al. Molecular Systems Biology
- Uncovering the mechanisms of Acinetobacter baumannii virulence
- (2017) Christian M. Harding et al. NATURE REVIEWS MICROBIOLOGY
- Overexpression of ppc or deletion of mdh for improving production of γ-aminobutyric acid in recombinant Corynebacterium glutamicum
- (2017) Feng Shi et al. WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY
- Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options
- (2017) Chang-Ro Lee et al. Frontiers in Cellular and Infection Microbiology
- A1S_2811, a CheA/Y-like hybrid two-component regulator from Acinetobacter baumannii ATCC17978, is involved in surface motility and biofilm formation in this bacterium
- (2017) Rong Chen et al. MicrobiologyOpen
- Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial
- (2017) Anna Giammanco et al. mSphere
- A novel genome editing platform for drug resistantAcinetobacter baumanniirevealed an AdeR-unrelated tigecycline resistance mechanism
- (2016) Vincent Trebosc et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Abrp, a new gene, confers reduced susceptibility to tetracycline, glycylcine, chloramphenicol and fosfomycin classes in Acinetobacter baumannii
- (2016) X. Li et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii
- (2016) Sibylle H. Lob et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Identification of Acinetobacter baumannii Serum-Associated Antibiotic Efflux Pump Inhibitors
- (2014) Catlyn Blanchard et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genomics of KPC-Producing Klebsiella pneumoniae Sequence Type 512 Clone Highlights the Role of RamR and Ribosomal S10 Protein Mutations in Conferring Tigecycline Resistance
- (2013) Laura Villa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase
- (2013) Q. Chen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Mechanisms and fitness costs of tigecycline resistance in Escherichia coli
- (2013) M. Linkevicius et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The Rise of Carbapenem-Resistant Acinetobacter baumannii
- (2012) Benjamin A. Evans et al. CURRENT PHARMACEUTICAL DESIGN
- The emergence of clinical resistance to tigecycline
- (2012) Yan Sun et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Antibiotic Use and Resistance in Long Term Care Facilities
- (2012) Laura W. van Buul et al. Journal of the American Medical Directors Association
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
- (2011) A.-P. Magiorakos et al. CLINICAL MICROBIOLOGY AND INFECTION
- Nosocomial bloodstream infections due to Acinetobacter baumannii, Acinetobacter pittii and Acinetobacter nosocomialis in the United States
- (2011) Hilmar Wisplinghoff et al. JOURNAL OF INFECTION
- Overexpression of Resistance-Nodulation-Cell Division Pump AdeFGH Confers Multidrug Resistance in Acinetobacter baumannii
- (2010) S. Coyne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Shining a Light on an Opportunistic Pathogen
- (2010) M. J. McBride JOURNAL OF BACTERIOLOGY
- Antibiotic resistance and its cost: is it possible to reverse resistance?
- (2010) Dan I. Andersson et al. NATURE REVIEWS MICROBIOLOGY
- The role of antibiotics and antibiotic resistance in nature
- (2009) Rustam I. Aminov ENVIRONMENTAL MICROBIOLOGY
- Isolation of Predation-Deficient Mutants of Bdellovibrio bacteriovorus by Using Transposon Mutagenesis
- (2008) J. J. Tudor et al. APPLIED AND ENVIRONMENTAL MICROBIOLOGY
- Acinetobacter baumannii: Emergence of a Successful Pathogen
- (2008) A. Y. Peleg et al. CLINICAL MICROBIOLOGY REVIEWS
- Structure and function of the LysR-type transcriptional regulator (LTTR) family proteins
- (2008) S. E. Maddocks et al. MICROBIOLOGY-SGM
- Acinetobacter Infection
- (2008) L. Silvia Munoz-Price et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started